59 related articles for article (PubMed ID: 3103160)
1. Disruption of positive- and negative-feature morphine interoceptive occasion setters by dopamine receptor agonism and antagonism in male and female rats.
Peart DR; Nolan CJ; Stone AP; Williams MA; Karlovcec JM; Murray JE
Psychopharmacology (Berl); 2024 Apr; ():. PubMed ID: 38580732
[TBL] [Abstract][Full Text] [Related]
2. Predicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendations.
Huskinson SL; Naylor JE; Rowlett JK; Freeman KB
Neuropharmacology; 2014 Dec; 87():66-80. PubMed ID: 24662599
[TBL] [Abstract][Full Text] [Related]
3. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats.
Koffarnus MN; Greedy B; Husbands SM; Grundt P; Newman AH; Woods JH
Psychopharmacology (Berl); 2009 Apr; 203(2):317-27. PubMed ID: 18807248
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
Millan MJ; Iob L; Péglion JL; Dekeyne A
Psychopharmacology (Berl); 2007 Apr; 191(3):767-82. PubMed ID: 17047933
[TBL] [Abstract][Full Text] [Related]
5. The discriminative properties of the D1 dopamine agonist dihydrexidine in the rat.
Schechter MD
Psychopharmacology (Berl); 1995 May; 119(1):79-84. PubMed ID: 7675953
[TBL] [Abstract][Full Text] [Related]
6. Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987.
Stolerman IP; Rasul F; Shine PJ
Psychopharmacology (Berl); 1989; 98(1):1-19. PubMed ID: 2498952
[No Abstract] [Full Text] [Related]
7. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
Carlson JH; Bergstrom DA; Walters JR
Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101
[TBL] [Abstract][Full Text] [Related]
8. Stimulus properties of dopaminergic drugs: comparisons involving selective agonists and antagonists.
Appel JB; Weathersby RT; Cunningham KA; Callahan PM; Barrett RL
Psychopharmacol Ser; 1988; 4():44-56. PubMed ID: 3293045
[TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus effects of a low dose of apomorphine in the rat.
Tang AH; Franklin SR
Psychopharmacology (Berl); 1987; 91(1):61-6. PubMed ID: 3103160
[TBL] [Abstract][Full Text] [Related]
10. Studies on the discriminative stimulus properties of apomorphine in rhesus monkeys.
Tang AH; Code RA
Psychopharmacology (Berl); 1989; 97(3):418-22. PubMed ID: 2497493
[TBL] [Abstract][Full Text] [Related]
11. Effects of selective dopamine receptor agonists in rats trained to discriminate apomorphine from saline.
Woolverton WL; Kamien JB; Goldberg LI
Pharmacol Biochem Behav; 1985 Apr; 22(4):577-81. PubMed ID: 3873077
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections.
Witkin JM; Nichols DE; Terry P; Katz JL
J Pharmacol Exp Ther; 1991 May; 257(2):706-13. PubMed ID: 1674533
[TBL] [Abstract][Full Text] [Related]
13. Different dopaminergic mechanisms for amfonelic acid, amphetamine and apomorphine.
Schechter MD
Pharmacol Biochem Behav; 1980 Oct; 13(4):497-500. PubMed ID: 7433481
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the stimulus properties of apomorphine are mediated by both D1 and D2 receptor activation.
Schechter MD; Greer NL
Life Sci; 1987 Jun; 40(25):2461-71. PubMed ID: 2953944
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
